New schizophrenia cases in Ontario, Canada have nearly tripled since cannabis was legalised in 2015, according to a ...

A new study from Canadian researchers has found that the proportion of new schizophrenia cases associated with cannabis use ...

Resilience factors were associated with less severe positive and negative schizophrenia symptoms, suggesting resilience may play a protective role.

A potential link between cannabis use and new cases of schizophrenia is in the spotlight again after a study found an ...

Bristol Myers Squibb clocked $10 million in sales for new schizophrenia drug Cobenfy in the fourth quarter of 2024, with the ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...

Potent cannabis linked to surging schizophrenia cases - New schizophrenia cases linked to cannabis use disorder more than ...

Schizophrenia and major depressive disorder (MDD) may be genetically associated with increased risk for constipation but only the latter association appears to be clinically significant, according to ...

Insurance firms launch mental illness coverage amid rising treatment rates in Korea Insurance companies adapt to changing ...

In people with treatment-resistant depression, investigational inhalable mebufotenin yielded a 15.5-point placebo-adjusted ...

Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, ...

Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of ma ...